Success Story: Dual NIW & EB1A Success Despite RFE! Our Expert Team Helped A Postdoctoral Fellow Get Approval

Client’s Testimonial:

“Thanks again to the team who have helped and assisted along the way!”

On August 30^th, 2024, and September 8^th, 2025, we received another I-140 NIW (National Interest Waiver) and EB1A (Alien of Extraordinary Ability) Approvals for a Postdoctoral Fellow in the Field of Molecular and Cellular Pathology (Approval Notice).

General Field: Molecular and Cellular Pathology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: China

State of Residence at the Time of Filing: New York

Approval Notice Date: August 30^th, 2024 & September 8^th, 2025 (NIW&EB1A)

Processing Time: 10 months, 11 days (NIW), and 15 months, 3 days (EB1A)

Case Summary:

We are excited to announce the approvals of both the I-140 National Interest Waiver (NIW) and the I-140 EB1A (Extraordinary Ability) petitions for our client, a distinguished expert in the field of molecular and cellular pathology. The NIW petition was approved in August 2024, followed by the EB1A approval in September 2025 after responding to a Request for Evidence (RFE).

Driving Advances in Molecular and Cellular Pathology

With a Ph.D. in cellular and molecular pathology, the Client has established himself as one of the few leading specialists in epigenome editing and profiling, vascular calcification, and reproductive toxicology. His proposed endeavor focuses on advancing understanding of the role of vascular smooth muscle cells in cardiovascular disorders, with far-reaching applications for improving public health outcomes.

The Client has authored 16 peer-reviewed journal articles (2 first-authored) and 6 abstracts (2 first-authored) in top-ranked venues, reflecting the quality and originality of his work. His research has been cited 477 times by independent scholars worldwide, further highlighting its influence and widespread adoption across the global scientific community.

Recognition Through Peer Review and Service

To demonstrate the Client’s standing as a trusted authority in his field, we emphasized his active role in shaping the scientific record. He has conducted at least 42 reviews for leading journals, a responsibility entrusted only to top experts. This service underscores both his expertise and his influence in guiding cutting-edge research.

Support and Independent Validation

The petition was further strengthened by four strong recommendation letters from internationally recognized experts in the field, including independent scholars who have cited and relied on the Client’s findings in their own work. These experts praised the originality of his methods, the significance of his contributions to cardiovascular and reproductive health research, and the transformative potential of his future endeavors.

“As a result of his studies, work as a peer reviewer, and other achievements, I attest to [Client’s] work being of significant value to the nation.”

Funding and Broader Impact

The Client’s research has also been supported by major funding agencies, including the National Institutes of Health (NIH), the American Heart Association (AHA), the National Science Foundation (NSF), the National Institute of Environmental Health Sciences (NIEHS), the National Centers for Translational Research in Reproduction and Infertility (NCTRI), and the National Heart, Lung, and Blood Institute (NHLBI). Such funding highlights the recognized national and global importance of his work.

A Successful Outcome

The approvals of both the NIW and EB1A petitions affirm the Client’s extraordinary record of success and the critical national importance of his work. These achievements are also a reflection of our firm’s expertise in presenting strong, well-documented petitions and, in the case of the EB1A, successfully addressing USCIS’s RFE with compelling evidence.

We are proud to have assisted the Client through this process and to have leveraged our experience to secure these outstanding results. His groundbreaking research in molecular and cellular pathology will continue to benefit the United States by advancing therapeutic strategies for cardiovascular disease, toxicology, and beyond.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.